Antioxidant Therapy with N-Acetylcysteine Plus Mesalamine Accelerates Mucosal Healing in a Rodent Model of Colitis
- 1 April 2006
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 51 (4) , 698-705
Abstract
The aims of this study were to examine the ability of the antioxidant N-acetylcysteine (NAC) and mesalamine (5-ASA) alone and in combination to affect TNBS-induced colitis in rat. Three days following induction of TNBS colitis rats were randomized to receive daily intracolonic treatment with NAC, 5-ASA, and NAC plus 5-ASA for 5 or 8 days. At the end of the treatment period macroscopic and microscopic colonic injuries were scored. Myeloperoxidase (MPO) activity and cytokine gene expression were measured in colonic tissues. Results indicated that treatment with NAC plus 5-ASA caused a significantly greater reduction in colonic injury than either agent alone. Furthermore, combination therapy inhibited significantly MPO activity and inflammatory cytokine gene expression in the distal colon of TNBS-treated animals. The beneficial effects of NAC plus 5-ASA on reduction of colonic injury and promotion of healing were most evident after 8 days of treatment.Keywords
This publication has 23 references indexed in Scilit:
- The Intestinal Anti-inflammatory Activity of UR-12746S on Reactivated Experimental Colitis Is Mediated Through Downregulation of Cytokine ProductionInflammatory Bowel Diseases, 2003
- Glutathione supplementation improves oxidative damage in experimental colitisDigestive and Liver Disease, 2003
- α-Phenyl- N - tert -Butylnitrone Provides Protection from Dextran Sulfate Sodium-Induced Colitis in MiceAntioxidants & Redox Signaling, 2002
- Replenishment of Glutathione Levels Improves Mucosal Function in Experimental Acute ColitisLaboratory Investigation, 2000
- Effects of antirheumatic agents on cytokinesSeminars in Arthritis and Rheumatism, 1996
- Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.Gut, 1995
- Oxidants and free radicals in inflammatory bowel diseaseThe Lancet, 1994
- Inhibition of leucocyte adhesion molecule upregulation by tumor necrosis factor alpha: a novel mechanism of action of sulphasalazine.Gut, 1993
- Role of reactive oxygen metabolites in experimental colitis.Gut, 1990
- Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitisCanadian Journal of Physiology and Pharmacology, 1988